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METHODOLOGY ARTICLE Open Access
Real-time tracking of complex
ubiquitination cascades using a
fluorescent confocal on-bead assay
Joanna Koszela1*, Nhan T. Pham1, David Evans1, Stefan Mann1, Irene Perez-Pi1, Steven Shave1, Derek F. J. Ceccarelli4,
Frank Sicheri4, Mike Tyers3 and Manfred Auer1,2*
Abstract
Background: The ubiquitin-proteasome system (UPS) controls the stability, localization and/or activity of the
proteome. However, the identification and characterization of complex individual ubiquitination cascades and their
modulators remains a challenge. Here, we report a broadly applicable, multiplexed, miniaturized on-bead technique
for real-time monitoring of various ubiquitination-related enzymatic activities. The assay, termed UPS-confocal
fluorescence nanoscanning (UPS-CONA), employs a substrate of interest immobilized on a micro-bead and a
fluorescently labeled ubiquitin which, upon enzymatic conjugation to the substrate, is quantitatively detected on
the bead periphery by confocal imaging.
Results: UPS-CONA is suitable for studying individual enzymatic activities, including various E1, E2, and HECT-type
E3 enzymes, and for monitoring multi-step reactions within ubiquitination cascades in a single experimental
compartment. We demonstrate the power of the UPS-CONA technique by simultaneously following ubiquitin
transfer from Ube1 through Ube2L3 to E6AP. We applied this multi-step setup to investigate the selectivity of five
ubiquitination inhibitors reportedly targeting different classes of ubiquitination enzymes. Using UPS-CONA, we have
identified a new activity of a small molecule E2 inhibitor, BAY 11-7082, and of a HECT E3 inhibitor, heclin, towards
the Ube1 enzyme.
Conclusions: As a sensitive, quantitative, flexible, and reagent-efficient method with a straightforward protocol,
UPS-CONA constitutes a powerful tool for interrogation of ubiquitination-related enzymatic pathways and their
chemical modulators, and is readily scalable for large experiments.
Keywords: Ubiquitin, Inhibitors, Confocal fluorescence, Bead-based assay, Ubiquitination assay
Background
Post-translational modification of protein substrates by
the small modifier protein ubiquitin regulates the
stability, localization, interactions, and activity of a
substantial fraction of the proteome. Disruption of the
ubiquitin-proteasome system (UPS) is associated with
many diseases, including cancer, neurological disorders,
and immune system dysfunction [1], and as a
consequence is a high priority area for drug discovery.
In the canonical ubiquitination cascade, the C-terminal
carboxylate of ubiquitin is first activated in an
ATP-dependent fashion by an E1 ubiquitin-activating
enzyme, followed by thioester transfer to an E2
ubiquitin-conjugating enzyme, before subsequent trans-
fer via an E3 ubiquitin ligase to a substrate lysine residue
and attachment through an isopeptide linkage. Repeti-
tion of this cascade enables a ubiquitin chain to be as-
sembled on the substrate through conjugation of further
ubiquitin moieties to one of the seven lysine residues on
ubiquitin itself. Different ubiquitin chain linkages can
specify different fates for the substrate. For example,
K48-linked chains target substrates to the 26S
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proteasome for rapid degradation, while K63-linked
chains can control the assembly of various protein com-
plexes. Protein monoubiquitination also occurs fre-
quently and can direct protein interactions, for example
in intracellular vesicular trafficking. Various ubiquitin
modifications can be read by dedicated reader domains
and can be reversed through the action of specific deubi-
quitinating enzymes. The human genome encodes two E1
enzymes, 38 E2 enzymes, over 600 E3 enzymes, over 100
deubiquitinating enzymes, as well as various associated
scaffolding subunits. The combinatorial promiscuity of
ubiquitin system enzymes, including redundant substrate
targeting by different E3s, has made the deconvolution of
UPS-mediated control far more difficult than originally
envisioned, with implications for UPS drug discovery. In
addition, only a limited number of small molecule inhibi-
tors of the UPS are available as mechanistic probes and
most of these inhibitors are only poorly characterized for
specificity [2]. The dearth of reliable methods to assess
molecular mode of action of chemical inhibitors with the
necessary level of quantification, time resolution and spe-
cificity has hindered UPS drug discovery [3–5].
The confocal scanning technology (CONA) was ori-
ginally developed to enable screening of combinatorial
chemical libraries directly on the solid bead-based
support, which in effect serves as a nanoscale assay
compartment [6–11]. The confocal sectioning of a
monolayer of ~ 100-μm-sized beads imaged on a fluor-
escence microscope equipped with a scanning stage
enables the high-throughput, highly sensitive detection
of binding events between a bead-linked small molecule
and a fluorescently labeled target protein in solution [6, 8].
Bead-based screening methods are miniaturized, versatile,
highly sensitive, quantitative and fast, and have proven
successful in identification of numerous small molecule
and peptidomimetic binders and inhibitors against diffi-
cult protein targets, such as HuR, Importin beta, and
LFA-1 [9–11].
To address the need for a robust technique attuned to
the multitude of complex UPS reactions, we developed a
fluorescence-based on-bead confocal imaging method,
termed UPS-confocal fluorescence nanoscanning
(UPS-CONA), for quantitative characterization of dy-
namic ubiquitination reactions in real time. We demon-
strate suitability of UPS-CONA for studying E1, E2, and
HECT E3 activities, both individually and in an inte-
grated enzyme reaction cascade. The modularity and
miniaturization of UPS-CONA, in combination with
high sensitivity, provides a powerful tool for deciphering
multi-step reactions by tracking the kinetics of ubiquitin
transfer in real time. In proof-of-concept experiments,
we apply UPS-CONA to investigate the specific activity
of selected ubiquitination inhibitors and uncover novel
inhibitory activities.
Results
A confocal on-bead ubiquitination assay—the concept
To exploit the advantages of the CONA technique in
the ubiquitination field, we developed UPS-CONA as a
method for detection and characterization of complex
ubiquitin enzyme-mediated reactions. In its new, rede-
fined form, the assay employs a substrate or enzyme of
interest, which is immobilized on a polymer micro-bead,
and a fluorescently labeled ubiquitin or ubiquitin-like
protein modifier (ULM) in solution (Fig. 1a). Upon ubi-
quitin conjugation to the on-bead substrate or enzyme,
the fluorescence emission intensity of conjugates is de-
tected by confocal imaging through the equatorial
cross-sectional plane of the beads and observed as a
fluorescent ring. The high sensitivity of on-bead assays
without the need for cumbersome washing steps is
achieved by the reduction of the background fluorescence
intensity through removal of out-of-focus light as a result
of confocal imaging. Consequently, the time-lapsed detec-
tion of fluorescent ubiquitin allows monitoring of the re-
action in real time. Using low concentrations of reactants,
both on-bead and in solution, allows the fluorescence
emission intensity detected at the cross section of the
beads to be linearly proportional to the amount of enzym-
atic conjugate (Additional file 1: Figure S1). After acquisi-
tion of confocal images of beads in a multi-well test plate,
the ring intensity of hundreds to thousands of
micro-beads forming a monolayer on the bottom of the
well is analyzed and quantified (Fig. 1b, c). Due to the size
of the beads (typically less than 120 μm in diameter), a
large number of technical measurement replicates are
possible, increasing statistical power (see “Methods” for
details).
The on-bead ubiquitination reaction allows for detec-
tion of ubiquitin and ULM conjugates on a variety of en-
zymes and substrates (Fig. 2). The charging of ubiquitin
to an E1 enzyme can be assayed by immobilizing the E1
on beads and incubating with ubiquitin in solution, to-
gether with Mg2+-ATP in reaction buffer. Alternatively,
an E2 enzyme can be placed on bead and incubated with
both ubiquitin and an E1 enzyme in solution to detect
thioester formation on the E2. Similarly, those E3 en-
zymes that form a direct thioester conjugate with ubi-
quitin, such as the HECT-type enzymes [12], can be
tested by immobilizing the E3 and incubating with ubi-
quitin, E1, and an appropriate E2 in solution. Finally, the
performance of an entire cascade can be quantified by
immobilization of a substrate of interest on beads in the
presence of ubiquitin and the appropriate E1, E2, and E3
enzymes in solution (Additional file 1: Figure S2). Im-
portantly, the flexibility, modularity, and single-bead
miniaturization of the UPS-CONA assay make it suitable
for a plethora of various ubiquitin-related reactions of
high complexity, which are difficult to investigate by
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existing methods. Using the same principle, the assay
setup can also be applied to monitor the release of ubi-
quitin from an immobilized E1 into the E2 in solution,
to track ubiquitination cascades in a step-by-step fashion
(Fig. 2) or to simultaneously compare activities of en-
zymes from the same class.
Monitoring activities of E1, E2, and HECT E3 enzymes
To test the broad applicability of UPS-CONA, we ap-
plied the method to different classes of ubiquitination
enzymes, namely E1, E2, and HECT E3 enzymes. First, a
His6-tagged version of the Ube1 ubiquitin-activating en-
zyme (E1) was immobilized on commercial Ni2+NTA
agarose beads, previously sieved to limit their diameters
to between 100 μm and 120 μm. The Ube1 beads were
transferred to a 384-well plate to form a monolayer and
were incubated with Cy5-labeled ubiquitin (Cy5-Ub) in
ubiquitination buffer as described in “Methods”. Blank
beads were used as control for unspecific Cy5-Ub bind-
ing, and reaction trials without ATP were used as a con-
trol for non-enzymatic Cy5-Ub binding to Ube1.
Ubiquitin loading onto Ube1 was monitored by confocal
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Fig. 1 Detection of ubiquitination using confocal nanoscanning (CONA). a A substrate protein is immobilized on polymer microbeads and
incubated with a suitable mix of conjugating enzymes and with a fluorescently labeled ubiquitin (red). Upon ubiquitin conjugation to the protein
substrate, a fluorescent “ring” will become detectable in the confocal image plane across the microbeads. b Images of beads in a 384-well plate
were acquired using the confocal scanning microscope Opera™ (Perkin Elmer) in brightfield for bead detection (top images) and in the
fluorescence emission channel of the dye on ubiquitin for detection of ubiquitin conjugates (bottom images). A reaction without ATP (−ATP) was
used as control for possible non-enzymatic binding. Intensity profiles across beads (blue and magenta lines) were used for quantification of
fluorescence emission intensity, which is proportional to the amount of conjugated ubiquitin at the concentrations used. c Bead cross-section
intensity profiles from b were acquired using ImageJ software. d Intensity profiles of > 100 beads in a test well were analyzed as detailed in
“Methods” to calculate average ring intensities in each well
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detection of the Cy5 fluorescence emission on bead and
quantified as detailed in the “Methods” section. The
fluorescent emission intensity denoting ubiquitin conju-
gation increased rapidly, within minutes of incubation
(Fig. 3a). Similar experiments were performed with an
immobilized E2 (Ube2L3, Fig. 3b), in the presence of
Cy5-Ub and an untagged Ube1 enzyme in solution.
Finally, an immobilized version of the E6AP ubiquitin
ligase, which is a host cell factor for human papillomavirus
E6-oncoprotein-induced degradation of p53 [13], was in-
cubated with Cy5-Ub, untagged Ube1, and Ube2L3 in so-
lution (E6AP, Fig. 3c). In all types of experiments, an
increase of the Cy5 fluorescence intensity corresponding
to ubiquitin thioester formation and/or conjugation was
observed over time. A slight decrease of the signal ob-
served after incubation for 90 min or longer was likely
due to thioester hydrolysis. Addition of the reducing re-
agent dithiothreitol (DTT) at the end of each reaction re-
vealed the proportion of conjugates attached through a
thioester to the immobilized proteins to be 60% on Ube1,
95% on Ube2L3, and 80% on E6AP (Fig. 3a–c, respect-
ively). The remaining signal on Ube1 is most likely to cor-
respond to the ubiquitin adenylate bound to the
adenylation site [14], while the remaining signal on E6AP
likely corresponded to isopeptide bond-linked ubiquitin
moieties due to auto-ubiquitination on E3 lysine residues
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Fig. 2 Applications of the UPS-CONA assay. UPS-CONA assay can be used to monitor various ubiquitin-related reactions. For example, ubiquitin
conjugation to E1 and E2 enzymes, HECT or RBR E3 ligases and substrate proteins can be followed by immobilizing the proteins or enzymes of interest
on polymer microbeads and incubating them with appropriate reaction components and with a fluorescently labeled ubiquitin (red). Increase in bead
fluorescence will indicate a successful reaction (a). Ubiquitin release from an on-bead substrate and transfer to a downstream cascade component can
be detected as a decrease of bead fluorescence (b). Ubiquitin transfer between different components of a cascade can also be observed (c)
Koszela et al. BMC Biology  (2018) 16:88 Page 4 of 13
[15]. As expected, Ube2L3 was exclusively charged with
thioester-bound ubiquitin under these conditions [16].
We successfully tested several other ubiquitination and
neddylation reactions using UPS-CONA, including ubi-
quitination of the tumor-suppressor protein p53
(Additional file 1: Table S1). Based on these results, the
bead-based assay appears suitable for monitoring various
reactions in the primary ubiquitination cascade and in
addition can be used to quantify the thioester-bound ubi-
quitin fraction relative to total bound ubiquitin.
Multiplexing bead populations in a single well
Miniaturization of the assay, and subsequently a poten-
tial screening setup, to the single bead level, allows for
modularity, multiplexing, and flexibility in assay format.
Each of the 200–400 beads placed into one well of a
384-well plate represents a separate technical measure-
ment replicate comparable with 200–400 replicate mea-
surements on a plate-based biosensor, thereby providing
enhanced statistical power. To establish a system for in-
vestigation of multiple reactions, typical for enzymatic
ubiquitination cascades, it was necessary to separately
detect, within a well, bead populations to which different
proteins were attached. The detection of mixed bead
populations can be achieved through labelling of mole-
cules involved in the reaction with spectrally distinct
fluorophores and by then mixing these bead populations
in a test well for detection with different fluorescence fil-
ters (Fig. 4a, b and Additional file 1: Figure S3). How-
ever, as this approach involves pre-labelling of proteins
of interest with dyes, which could affect their activity, a
method based on differentiating the bead populations by
size was also established. Two bead populations were
used: small beads of 40–70 μm in diameter and large
beads of 100–120 μm in diameter (Fig. 4c). To confirm
that the His6-tag-Ni2+NTA attachment was stable
enough to prevent transfer between different bead popu-
lations in one well over time, small beads pre-incubated
with His6-eGFP were mixed with blank large beads and
vice versa in the same well (Fig. 4d). The small and
large bead populations were separately detected
without significant overlap by precisely setting the bead
size parameters (Additional file 1: Figure S4). No
protein exchange between the beads was observed
under reaction conditions, likely due to local rebinding
effects, which leads to strong compartmentalization of the
His6-tagged proteins on the bead surface, in conjunction
with non-saturating protein amounts (Additional file 1:
Figure S1). These results demonstrated that each bead
can be considered as a separate reaction unit, thereby
allowing monitoring of more than one reaction in a
single well.
Tracking a multi-step ubiquitination cascade
A challenge inherent to multi-enzyme reactions such as
for the ubiquitination cascade is the tracking of activities
of various enzymes in a single experiment. To demon-
strate the suitability of UPS-CONA for monitoring sev-
eral serial steps in a reaction cascade, we chose to
reconstitute the entire reaction for the E6AP, a clinically
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Fig. 3 Ubiquitination activity of E1, E2, and HECT E3 enzymes detected
over time using UPS-CONA. His6-tagged enzymes Ube1 (a), Ube2L3
(b), or E6AP (c) were immobilized on Ni2+NTA agarose microbeads,
placed in a 384-well plate and incubated in the reaction buffer at 37 °C
in the presence of Cy5-labeled ubiquitin (a), Cy5-labeled ubiquitin and
untagged Ube1 (b) or Cy5-labeled ubiquitin, untagged Ube1 and
Ube2L3 (c). Reactions without ATP (− ATP) were used as controls for
non-enzymatic binding of Cy5-Ub to the beads. Reactions were
performed in triplicates. At the end of each reaction, DTT was added
to remove thioester-bound Cy5-Ub from the on-bead enzymes to
quantify non-thioester-bound fraction. Images were acquired on the
confocal scanning microscope Opera™ (Perkin Elmer), in brightfield for
detection of beads and in Cy5 fluorescence emission for detection of
Cy5-Ub conjugates. Data were analyzed as described in “Methods”.
Average ring intensities in each well over time are represented,
corresponding to Cy5-Ub conjugated to the on-bead enzyme
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relevant E3 enzyme implicated in cervical cancer [17]. A
His6-tagged Ube1 enzyme was attached to small beads
and a His6-tagged E6AP to large beads (Fig. 5a). The
two bead populations were then mixed together in one
well and incubated with the ubiquitination reaction solu-
tion, containing Cy5-Ub and ATP (see “Methods”). The
small Ube1 beads became fluorescent (Fig. 5b) and the
ring intensity reached a plateau within minutes, indicat-
ing a successful Cy5-Ub conjugation to Ube1. At this
point, we added a non-tagged Ube2L3, the cognate E2
enzyme for E6AP. As the ubiquitin was transferred from
the on-bead Ube1 to Ube2L3 in solution, the Cy5-Ub
signal on Ube1-bound beads decreased over time
(Fig. 5b, c). Simultaneously, the Cy5-Ub signal increased
on the E6AP-bound large bead population, indicating
that ubiquitin was conjugated from Ube2L3 in solution
to the E6AP on beads (Fig. 5b, c). This result demon-
strated the ability of the UPS-CONA assay to monitor
multiple reactions in parallel in a single reaction well.
Target deconvolution of ubiquitination inhibitors
Despite the therapeutic potential of the UPS in cancer
and other disease areas, the activity and selectivity of
many reported molecules that modulate the UPS are not
fully characterized. In particular, assessment of the speci-
ficity of a potential inhibitor towards more than one re-
action in a cascade requires development of multiple
assays. We reasoned that an ideal assay system for ad-
dressing target specificity in the UPS should allow en-
zymatic reactions of the entire cascade to be monitored
in parallel. Quantitative and time-resolved monitoring of
ubiquitin transfer through the E1-E2-E3 cascade to the
final substrate would provide mechanistic insight into
the potential effects of an inhibitor at each step.
This information would allow triage of hit compounds
that lacked the necessary specificity for lead develop-
ment. To investigate whether UPS-CONA can be used
to assess selectivity of ubiquitination inhibitors, we used
our multi-step ubiquitination assay to test a selection of
known ubiquitination inhibitors: an E1 inhibitor PYR-41
[18], the E2 inhibitors BAY 11-7082 [19] and CC0651
[20, 21], and the HECT E3 inhibitors clomipramine [22]
and heclin [23] (Additional file 1: Figure S5).
BAY 11-7082 inhibits Ube1
The small molecule BAY 11-7082 was first identified as an
inflammation inhibitor [24] and has been extensively used
as such. More recently, Ube2L3 and other E2 enzymes
and ubiquitination enzymes have been identified as direct
targets of BAY 11-7082 [19]. In our multi-activity
UPS-CONA assay with Ube1, Ube2L3, and E6AP, we
found that BAY 11-7082 decreased the rate of ubiquitin
transfer for all individual reaction steps of the cascade
(Fig. 6a, Additional file 1: Figure S5). The combined,
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indicating the absence of protein transfer between the beads
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overall inhibitory effect of BAY 11-7082 on E6AP was
stronger than that of the E1 inhibitor PYR-41 (Fig. 6a).
Interestingly, also heclin showed a mild inhibitory effect
on Ube1 (Fig. 6a). To confirm the activity of BAY 11-7082
and heclin directly on Ube1, we tested the compound in
an on-bead assay with Ube1 alone in the absence of E2 or
E3 enzymes (Fig. 6b). The inhibitory effect of BAY
11-7082 on Ube1 was concentration-dependent, with an
IC50 below 1 μM, while IC50 of its known target Ube2L3
in our bead-based assay was 7.5 μM (Additional file 1:
Figure S6). To confirm that the observed inhibitory activ-
ity was not an artifact caused by effects on the fluorescent
labels, we tested the compounds in a standard SDS-PAGE
ubiquitination assay. After optimizing the reaction condi-
tions (described in detail in the “Methods” section), we de-
termined that BAY 11-7082 inhibited Ube1 with an IC50
of ~ 4.6 μM in the gel-based assay (Fig. 6c, d). The magni-
tude of this effect was similar to the inhibition observed
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Fig. 5 Real-time tracking of a ubiquitination cascade in a single well. a Schematic of the multi-step ubiquitination assay. Ube1 immobilized on small
beads and E6AP immobilized on large beads were placed together in one well with a fluorescent Ub. In the presence of ATP, ubiquitin was loaded
onto Ube1 (1), forming a fluorescent ring on small beads. Upon addition of Ube2L3 to the solution, ubiquitin was transferred to Ube2L3 and a
decrease in ring intensity on small beads (Ube1) was observed (2). Simultaneously, as Ube2L3 further transfers the fluorescent Ub to E6AP, ring
intensity on large beads increased (3). b The reaction was monitored by imaging on the confocal scanning microscope Opera™ (Perkin Elmer) over
time. Images were acquired in the brightfield (LED) and Cy5 fluorescence emission detection channels (640 nm). Ring intensities from small (Ube1)
and large (E6AP) beads were analyzed as described in “Methods”. Ubiquitin loading on Ube1 (blue line) and conjugation on E6AP (red line) which
occurred simultaneously in each well are represented in charts, corresponding to wells as indicated: b with ATP and Ube2L3 (+ ATP + Ube2L3),
c without Ube2L3 (+ATP −Ube2L3), and d without ATP (−ATP + Ube2L3). Shown are exemplary images at the start of experiment (0), after adding
ATP (1), and after 2-h incubation (3). Over time, the intensity of the Cy5-Ub conjugates decreased on Ube1 beads and increased on the E6AP beads
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for other targets of BAY 11-7082 [19] and may in part ex-
plain the pan-inhibitory effect of BAY 11-7082 on E2 en-
zymes. In a similar experimental design, we confirmed
that the E3 inhibitor heclin also affected ubiquitin loading
onto Ube1 (Fig. 6b, d). The IC50 of 16 μM for this inhibi-
tory effect of heclin was somewhat higher than the IC50
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Fig. 6 Characterization of ubiquitination inhibitor selectivity. BAY 11-7082, CC0651, clomipramine, heclin, and PYR-41 were tested for selectivity in
a multi-step UPS-CONA assay. a Effects of inhibitors on the Ube1-Ube2L3-E6AP cascade. Inhibition of Ub charging to Ube1 was measured as
decrease in fluorescent ubiquitination signal on Ube1 prior to adding Ube2L3 to the reaction. Inhibition of the Ube1-Ube2L3 transfer was
measured as a decrease of Ub signal from Ube1 after adding Ube2L3. Final effect on E6AP ubiquitination was measured as a decrease in
ubiquitin conjugation levels to E6AP. Detected signal was normalized to DMSO controls and fitted where possible by non-linear regression to the
four-parameter logistic model using GraFit 7. b Comparison of inhibition effects on Ube1 observed using UPS-CONA. Ube1 was immobilized on
beads, preincubated with inhibitors, and subjected to UPS-CONA. On the left, dose-dependent inhibition of ubiquitin loading to immobilized
Ube1 was observed for PYR-41, BAY 11-7082, and heclin. On the right, quantification of the non-thioester-bound ubiquitin fraction remaining
after treatment with DTT revealed potentially different mechanisms of action. c Gel-based assay for BAY 11-7082 and heclin inhibition of Ube1.
Ube1 was preincubated in the ubiquitination buffer with inhibitors at indicated concentrations prior to adding WT-ubiquitin and ATP. After 5 min
at 30 °C, the reactions were stopped by adding SDS loading buffer. Samples were resolved by SDS-PAGE and revealed by Western blot with anti-
ubiquitin and anti-Ube1 antibodies. d Ube1 activity (Ube1~Ub thioester ratio to total Ube1) was quantified using densitometric analysis (ImageJ).
The chart shows corresponding inhibition curve generated in at least two independent experiments
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values of 6–7 μM reported for inhibition of other HECT
E3s [23] but nonetheless suggested that E1 inhibition may
also account for some activity of heclin. In contrast, we
found that CC0651 and clomipramine had no detectable
effect on Ube1 activity (Fig. 6a, b).
Mechanistic insights into enzyme inhibition
As the UPS-CONA readout combines quantitative and
time-resolved detection of ubiquitination, we reasoned
that it should be possible to resolve selected aspects of
inhibition mechanisms. We therefore analyzed the
dose-response effects of the aforementioned inhibitors
on ubiquitin loading on Ube1 on beads, followed by re-
duction with DTT (Fig. 6b). In this format, the signal
remaining after DTT treatment would correspond to
ubiquitin that interacted with Ube1 through a
thioester-independent mechanism. Analysis of the inhib-
ition curves revealed that BAY 11-7082 inhibited up to
~ 50% of ubiquitin loading onto Ube1 (Fig. 6a, b), which
suggested that this compound may act on only one ubi-
quitin binding site of Ube1. Since ubiquitin cannot oc-
cupy the second thioester site on Ube1 without binding
first to the adenylation site, we inferred that the thioe-
ster site was likely affected. The DTT-resistant signal
was dose-dependent, reaching ~ 60% at highest com-
pound concentration used (Fig. 6b, right). This result indi-
cated that the proportion of the thioester-bound ubiquitin
was reduced by BAY 11-7082, consistent with an effect on
the thioester site on Ube1. This mechanism implied a
similar mode of action of BAY 11-7082 as described previ-
ously for E2 enzymes, by forming a covalent adduct with
the reactive cysteine residues [19]. In contrast, the effect
of heclin on Ube1 was less pronounced and similar to
PYR-41 in the shape of the inhibition curve (Fig. 6a, b).
However, the proportion of DTT-resistant signal remained
unchanged upon increasing heclin concentrations (Fig. 6b,
right), suggesting that heclin acts through a different
mechanism than PYR-41 or BAY 11-7082 [23]. As re-
vealed by dose-response curves and DTT treatment,
CC0651 and clomipramine did not affect Ube1 activity,
which was confirmed in SDS-PAGE ubiquitination assays.
Discussion and conclusions
We developed and validated an on-bead confocal detec-
tion method called UPS-CONA which is suitable for
studying individual enzymatic activities, including vari-
ous E1, E2, and HECT-type E3 enzymes. We also show
that the various ubiquitin-E1-E2-E3 reaction intermedi-
ates of a ubiquitination cascade can be followed in a
single reaction vessel using an exemplary enzymatic cas-
cade from Ube1 through Ube2L3 to E6AP in a
time-resolved manner. A dynamic, confocal detection of
fluorescent ubiquitin conjugates ensures a timely, sensi-
tive readout, and a straightforward protocol can be easily
automatized for large-scale experiments. Furthermore,
our integrated assay is suitable for studying effects of
small molecule inhibitors upstream or downstream of
the presumptive target against which an inhibitor was
originally identified.
The multi-step monitoring capability of the
UPS-CONA assay allowed for identification of a new in-
hibitory activity of BAY 11-7082 towards Ube1. This in-
formation is important for the ubiquitin community, as
this activity will need to be taken into account in assays
using this compound so far known as a broad E2 en-
zyme, but not E1 enzyme inhibitor [19]. To make deci-
sions on further development of any hit compound from
a binder screen or an enzymatic screen, the selectivity
information is critically important. UPS-CONA resolves
biochemical mode of action in one well of a 384-well
plate with picomole amounts of reagents, and may be
used for selectivity assays, either based on enzyme or
ubiquitin mutations, or structure-activity relationships of
hit series. Given the small amounts of enzymes with
conventional tags needed for UPS-CONA, combined
with the sensitivity and time-resolved capabilities dem-
onstrated in this work, this method should facilitate the
study of reaction mechanisms, mode of action of inhibi-
tors, and high-throughput screening campaigns.
UPS-CONA may be parallelized further using different
bead sizes to allow simultaneous monitoring of ubiquiti-
nation of different substrates in the same reaction or
adapted to monitor deubiquitinating enzyme and
ubiquitin-binding domain activities. Ubiquitin-like modi-
fiers, for example SUMO or NEDD8, may also be moni-
tored in similar assay formats or used for bead-based
deconvolution of multiple modification types on a single
substrate. Given the robustness of the on-bead fluores-
cent ring readout to interfering fluorescence from the
reactions solutions [7, 8], a lysate-based assay may also
be used to study reactions under more physiological
conditions, without the need for prior purification of re-
action components.
As a technique which requires protein immobilization,
bead-based biosensors like UPS-CONA have limitations
similar to other comparable methods, particularly
plate-based biosensors such as enzyme-linked immuno-
sorbent assay (ELISA) or surface plasmon resonance
(SPR). Often equilibrium constants, and kinetic rate con-
stants of binding and enzymatic reactions with one reac-
tion partner immobilized to a bead matrix or plate
surface, differ from the constants obtained from experi-
ments performed in homogeneous solution [8]. While the
assay may not reflect the exact kinetic parameters mea-
sured in solution, it is of great value for a larger-scale
comparative evaluation of activities and in particular of in-
hibitor selectivity, which we showcase in this work. Re-
lated to the immobilization method, contrary to other
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techniques, UPS-CONA offers a great choice of attach-
ment type which can be used according to the available
protein tagging type and reagents. In our study, we used
Ni2+NTA-His6-tag affinity for protein attachment to
beads; however, other types of immobilization methods
can be used such as antibodies and biotin-streptavidin.
Ideally, to avoid any leakage of proteins from the beads,
covalent attachment would be preferable, such as amine
crosslinking with N-hydroxysuccinimide esters. As any
other fluorescence-based method, UPS-CONA may be
affected by fluorescence interference, quenching or
bleaching. Although we did not observe such effects under
conditions used in this work, this aspect has to be taken
into consideration when designing experiments to make
sure that suitable controls are included for
normalization. Another limitation of the technique may
come from the instrumentation used. Confocal scan-
ning under high magnification will provide great reso-
lution, but may be relatively slow and therefore not
suitable for monitoring fast reactions, as we demon-
strated with ubiquitin charging onto Ube1. However,
slower reactions and end point effects are easily mea-
sured and, with the advancements in microscopy tech-
niques, the assay detection speed is likely to improve.
The suitability of off-the-shelf confocal imaging instru-
mentation and commercially available reagents should
enable UPS-CONA technology to become a broadly ap-
plicable method. UPS-CONA should therefore be of
value for exploring the interactions and activities within
combinatorially complex UPS cascades, for identification
and characterization of new small molecule probes, and
for facilitating UPS drug discovery.
Methods
Inhibitors
BAY 11-7082, clomipramine, and heclin were purchased
from Sigma-Aldrich (cat. no B5556, C7291 and
SML1396, respectively). PYR-41 was purchased from
Calbiochem (cat. no 662105) and CC0651 was provided
by the Tyers group. The masses and purity of com-
pounds were confirmed by analytical HPLC and LC/MS.
Proteins
The following proteins were purchased from BostonBio-
chem: wild type ubiquitin (cat. no U-100H); untagged
human recombinant ubiquitin-activating enzyme (UBE1)
(cat. no E-304); N-terminally His6-tagged human recom-
binant ubiquitin-activating enzyme (UBE1) (cat. no
E-305); human recombinant E6AP (UBE3A) with a
C-terminal His6-tag (cat. no E3–230).
Protein expression and purification
His6-tagged Ube2L3 was expressed from pET28a-LIC
(provided by the Sicheri group) in BL21(DE3) E. coli.
One-liter cultures were grown at 37 °C in LB and induced
with 0.5 mM isopropyl β-D-1-thiogalactopyranoside
(IPTG) at 20 °C overnight. Cells were harvested by centri-
fugation at 4000 rpm, 4 °C, lysed in lysis buffer (50 mM
sodium phosphate buffer pH 8, 400 mM NaCl, 10 mM
imidazole, 10 mM β-mercaptoethanol, protease inhibitor
cocktail (Roche) with lysozyme (Sigma-Aldrich), and
Benzonase Nuclease (Sigma-Aldrich, cat. no E8263)), and
sonicated on ice for 1 min in 10-s pulses at 50% of max-
imum power (Sonic VibraCell). The lysate was cleared by
centrifugation at 4000 rpm, 4 °C, and incubated in rota-
tion with pre-equilibrated 2 to 4 mL of 50% slurry Ni2+
NTA beads (Qiagen) for 2 h at 4 °C prior to standard
histidine-tag protein purification according to manufac-
turer’s instructions. Proteins were eluted in lysis buffer
containing 300 mM imidazole. To obtain untagged
Ube2L3, the His6-tag was removed with thrombin. Pro-
tein purity was analyzed by SDS-PAGE and by analytical
HPLC. Protein concentration was measured by UV-Vis
(NanoDrop, ThermoScientific) based on absorption at
280 nm and stray light correction at 330 nm.
Expression, purification, and labelling of Cys0-ubiquitin
Cys0-Ub (ubiquitin with an N-terminal cysteine
insertion) was expressed as TEV-cleavable histidine6,
glutathione-S-transferase (GST) fusion from pETM-30
plasmid (provided by the Sicheri lab) in BL21(DE3) E.
coli. Harvested cells were lysed and purified on Ni2
+NTA resin as above, then the tag was cleaved overnight
with TEV protease in 10 mL elution buffer with 2 mM
DTT. Contaminants, TEV, and cleaved tag were re-
moved by perchloric acid precipitation (pH 4.5) and cen-
trifugation at 4 °C, 14000 rpm. Cys0-Ub was then
dialyzed into 50 mM NaOAc pH 4.5 and purified on a
5-mL MonoS column (Pharmacia Biotech) using ÄKTA
Explorer FPLC purification system (Amersham Pharma-
cia Biotech). Elution volumes of 0.5 mL were analyzed
by SDS-PAGE and pure fractions were pooled and dia-
lyzed into 20 mM HEPES, 100 mM NaCl, and 0.5 mM
TCEP pH 7.0. The concentration was measured by
UV-Vis (NanoDrop, Thermo Scientific) and adjusted to
500 μM using Amicon-Ultra filter spin columns with
3 kDa cutoff (Merck Millipore).
For labelling, maleimide-Cy5 (GE Healthcare) was dis-
solved under argon in 100% dry DMSO to obtain
50 mM stock solution, aliquoted, and kept at − 20 °C.
Labelling reactions were performed in 100-μL volumes.
For 3 h at 25 °C, 300 μM of Cys0-Ub was incubated with
2.5 mM maleimide-Cy5 on a shaking platform, then
purified by size exclusion chromatography over a PD10
column (GE Healthcare). Elution fractions were analyzed
by HPLC, and the fractions labeled Cy5-Ub with < 1%
free Cy5-maleimide were pooled together. The purity of
the sample was assessed by SDS-PAGE and the
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Cy5-ubiquitin concentration was measured by UV-Vis
(NanoDrop, Thermo Scientific) based on Cy5 absorption
at 649 nm, prior to being aliquoted and stored at − 80 °C.
Western blots
The proteins (E1, E2s, ubiquitin) were run on 12% Bolt
Bis-Tris Plus SDS-PAGE gels (Thermo Fisher Scientific),
transferred to a 0.2-μm nitrocellulose membrane (BioRad),
and incubated with mouse anti-6His-tag antibody (1:500,
Roche, cat. no 11 922 416 001), mouse anti-Ub antibody
(1:1000, Enzo, cat. no ADI-SPA-203) or rabbit anti-Ube1
antibody (1:1000, Enzo, cat. no BML-PW8395), and infra-
red dye-coupled goat anti-mouse or anti-rabbit secondary
antibody (1:20,000, LI-COR, cat. no 925-32210 and
925-32211). Blots were scanned using an infrared imager
(Odyssey, LI-COR Biosciences) at 800 nm.
Gel-based Ube1 activity assay
In 10-μL volumes, 200 nM Ube1 was pre-incubated with
compounds in indicated concentrations or DMSO as
control for 15 min in 50 mM Tris pH 7.5, 5 mM MgCl2,
before adding 5 μM WT Ub and 1 μM ATP. The reac-
tions were incubated at 30 °C for 5 min and stopped by
adding SDS loading buffer. The samples were resolved
by SDS-PAGE and visualized by Coomassie staining
(SimplyBlue™, Invitrogen), or by Western blotting with
anti-Ube1 and anti-Ub antibodies.
Bead preparation
Nickel nitrilotriacetic acid (Ni2+NTA) agarose micro-beads
were purchased from Qiagen (cat. no. 30250). Before use,
beads were filtered through various mesh sizes (40, 70, 80,
100, and 120 μm) using cell strainers (Corning cat.
352340, 352350, and 352360) or nylon-woven net filters
(Millipore cat. no. NY8004700 and NY2H04700) to obtain
beads in specific size ranges. Beads were then washed thor-
oughly with binding buffer (0.3 M NaCl, 20 mM HEPES
pH 7.5, 0.01% Triton X-100) and brought back to 50%
slurry. One microliter of 100–120 μm filtered beads per
well of a 384-well plate was used to form a monolayer with
around 50% coverage of the well bottom surface. The vol-
umes and amounts were scaled up according to the re-
quired number of wells.
Immobilizing protein on beads
The estimated bead loading capacity as provided by the
manufacturer is around 50 mg per 1 mL of the 50%
slurry solution for a protein of around 30 kDa. One
microliter of beads would have a protein loading amount
equal to 50 μg of protein. Generally, we used a max-
imum of 0.5 μM in 20 μL of on-bead protein per well
corresponding to 300 ng, which is over 160-fold below
saturating amounts. The optimal amount of protein on
bead for effective signal detection was determined by
using a His6-tagged Emerald Green Fluorescent Protein
(emGFP) standard. A linear correlation between the
amount of on-bead emGFP and ring intensity held for
values equal to and below 10 pmoles/well (Additional file 1:
Figure S1). It was also verified that His6-tagged proteins
were stably attached to the beads for several hours
under typical experimental conditions, which is prob-
ably due to fast on and off rates corresponding to mi-
cromolar dissociation constants given by the tagging
system (Additional file 1: Figure S7). The beads were
incubated with the desired quantity of His6-tagged pro-
tein (typically 2.5 pmoles per well, or 125 nM) in
ice-cold binding buffer on a shaker at 1000 rpm for at
least 30 min at 8 °C. After incubation, the beads were
extensively washed with binding buffer and the volume
of bead solution was adjusted to 10 μL per well.
On-bead ubiquitination reaction
Beads with attached proteins were distributed in 10-μL
volumes into microplate wells (black, flat glass bottom
384-well plate, MMI PS384B-G175) using a wide bore
pipette tip (Rainin RC-250W). Ubiquitination mixes
were prepared to obtain final concentrations in 20 μL as
follows: 500 nM Cy5-labeled ubiquitin (Cy5-Ub), 50 nM
Ube1, 0.5 μM Ube2L3, 5 mM ATP where appropriate, in
50 mM Tris pH 7.5, 5 mM MgCl2. Ubiquitin-activating
reactions with on-bead Ube1 were performed with
Cy5-Ub and ATP. Ubiquitin-charging reactions with
on-bead Ube2L3 were performed with Cy5-Ub, Ube1,
and ATP. Ubiquitin-charging/conjugation to on-bead
E6AP were performed with Cy5-Ub, Ube1, Ube2L3, and
ATP. The plate was incubated at 37 °C and the reactions
were monitored over time. For determination of propor-
tion of thioester-bound ubiquitin, 50 mM DTT was
added at the end of the reaction and imaged again after
10 min incubation.
Multi-step ubiquitination reactions
For one well of a 384-well plate, 20 μL reactions were pre-
pared containing 0.2 μL of 50% slurry small (70–80 μm
diameter) Ni2+NTA agarose beads with 50 nM immobi-
lized Ube1; mixed with 1 μL of large (100–120 μm) beads
with immobilized 200 nM E6AP, and 500 nM Cy5-Ub in
50 mM Tris pH 7.5, 5 mM MgCl2. The beads were prein-
cubated with compounds for 15 min in concentrations as
indicated. Reactions were imaged on the Opera™ High
Content Screening System (Perkin Elmer) before and after
adding 5 mM ATP. At this point, 500 nM Ube2L3 simi-
larly preincubated with compounds was added where
appropriate and the reaction was imaged over time for at
least 2 h. For inhibitor activity evaluation, the well
averages were normalized against the DMSO control and
the data was fitted using non-linear regression to a
four-parameter logistic IC50 function using GraFit 7 [25].
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Bead imaging
Images were acquired on the Opera™ High Content
Screening System (Perkin Elmer) at 30.0 μm above well
bottom, at × 20 magnification with air lenses (20× Air
LUCPLFLN, NA = 0.45). Brightfield and two fluorescent
channels for detection of emGFP and Cy5 were used in
the following settings: excitation wavelength 640 nm
(Cy5) and 488 nm (emGFP); emission filters: 690/70 nm
(Cy5) and 520/35 nm (emGFP). Typically, 77 images from
the center of the well were taken to ensure near-full well
coverage and to visualize > 100 beads per well, and a well
sublayout with 20% image field overlap was applied to
allow consequent image stitching. Image data were ana-
lyzed using ImageJ and a custom MatLab script.
Data analysis
Full well images are stitched together from multiple in-
dividual microscope images using the Grid/Collection
Stitching Plugin for ImageJ [26]. The stitched images
from each channel, either brightfield or fluorescent, are
analyzed for each well in a well plate. The detection in
the brightfield channel allows detection of all the beads
in a given well, including those with only weak or no
fluorescence signal. An edge detection algorithm and
Gaussian filtering is applied to the image, followed by a
circular Hough transfer to identify circles in the image
within a required diameter range (typically between 100
and 120 μm) representing the beads. A canonical list of
bead positions and radii in each well is compiled by cor-
relating the beads detected from all the imaging chan-
nels. Beads which are incomplete and overlapping or
coincide with the image edges are removed from the list.
A pre-determined number of profiles (typically 10) is
taken across each bead. The peaks representing the
“ring” and the mean of the 20–80th percentiles of the
profile intensity between the peaks representing the
background bead intensity are identified for each profile.
A profile “intensity” is computed by subtracting the
background from the peak intensity. The mean of these
background-corrected ring intensity measurements for
each bead is computed, giving the bead intensity. If more
than one fluorophore is used in the experiment, the ratio
of fluorescence emission intensities of two fluorophores
detected on bead is used for an enhanced quantification
as it allows for correction against a reference fluoro-
phore, such as a second label on the assayed protein
immobilized on beads. Ratiometric analysis is performed
by calculating the ratio of the bead intensity of the same
bead in multiple fluorescent channels. The mean bead
ring intensity of each well in each channel is calculated
as the average bead intensity of all the beads in the well.
For each well, the mean bead ring intensity and standard
deviation are calculated.
Additional file
Additional file 1: Contains Supplementary Figures S1-S7. Figure S1.
Ring fluorescence intensity is linearly proportional to the amount of
bead-bound fluorescent substrate and is consistent across a test plate.
Figure S2. On-bead ubiquitination of a protein substrate, p53. Figure S3.
Fluorescence excitation and emission spectra for simultaneous detection
of three different fluorescent-fusion proteins. Figure S4. Bead detection
and analysis allows for differential detection of mixed small and large
bead populations. Figure S5. Inhibitory effects observed in time-resolved
ubiquitination cascade reactions. Figure S6. Concentration-dependent
inhibitory activity of BAY 11-7082 observed on eGFP-Ube2L3 using
UPS-CONA. Figure S7. Ring fluorescence intensity is stable over time and
remains linearly proportional to the amount of bead-bound fluorescent
substrate. Table S1. UPS-CONA is a broadly applicable assay. (DOCX 6279 kb)
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